Rb. Sewell et al., INTRACELLULAR BINDING IS AN IMPORTANT DETERMINANT OF THE AVID HEPATIC-UPTAKE OF THE HIGH CLEARANCE DRUG OMEPRAZOLE, Biochemical pharmacology, 48(4), 1994, pp. 846-849
The contribution of intracellular storage to hepatic uptake of the hig
h clearance drug, omeprazole, was examined in the recirculating isolat
ed perfused rat liver preparation. Following injection of [H-3]omepraz
ole (7.5 mu Ci, 5 mg) into the portal vein over 1 min, livers were per
fused for 5 min (N = 3) or 30 min (N = 3) and then homogenized at 4 de
grees and fractionated by differential centrifugation. Radiolabelled o
meprazole and metabolites were determined by scintillation counting of
fractions of eluant from HPLC. Seventy per cent of drug had been take
n up by the liver at 5 min and 85% at 30 min, with unchanged drug repr
esenting 43 and 7.4%, respectively, of drug taken up. At both times, 7
0-75% of intracellular unchanged drug and the major metabolites were l
ocated in the cytosol, and the cytosol:perfusate concentration ratio w
as approximately 10:1. Mitochondrial, lysosomal and microsomal fractio
ns contained relatively little drug. Extensive cytosolic binding of om
eprazole therefore contributes substantially to the initial avid hepat
ic first-pass uptake of this drug.